Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Lateral elbow pain, often referred to as lateral elbow tendinopathy or tennis elbow, can greatly limit daily activities. This research compares two treatment approaches to see which might better help people with this condition. The study involves adults referred for lateral elbow pain and evaluates if the Think in Nerve Length and Layers TINLL method is more effective than traditional therapy techniques. Participants are assigned to one of two groups based on their previous treatments a traditional treatment group or a TINLL group. The traditional group receives weekly treatments for 4 to 6 weeks, including wrist extensor stretching and strengthening, soft tissue work, joint mobilization, taping, ergonomic advice, electrical nerve stimulation, and wrist splinting. The TINLL group has treatments every 1 to 2 weeks over 4 to 6 weeks, focusing on joint and tendon mobilization, elastic taping of muscles and nerves, stretching and strengthening of elbow and upper arm muscles, and ergonomic strategies. After one month, participants may choose to switch groups if they wish. Participants undergo assessments before treatment, at 2 weeks, 4 weeks, and at the end of treatment. These include pain rating scales, grip strength tests, pinch strength tests, and functional surveys common for elbow pain. Six months after treatment, follow-up calls assess pain, function, and use of taping or home exercises. The study monitors changes over time to understand how each treatment impacts pain and function in lateral elbow tendinopathy.
Actively Recruiting
Cardiovascular disease often leads to hospitalization and disability in older adults. This research aims to improve recovery of aerobic fitness and physical function in older cardiac patients by comparing a new high intensity training program with the traditional moderate intensity cardiac rehabilitation exercises. The study focuses on older adults who have experienced recent heart events like myocardial infarction or percutaneous interventions, seeking better ways to reduce disability and improve health outcomes. Participants will be randomly assigned to one of two exercise programs a combined high intensity interval aerobic training HIIT with high intensity resistance training HIRT, or the usual moderate intensity continuous aerobic training MICT with moderate intensity resistance training MIRT used in cardiac rehabilitation. Both approaches are performed during Phase 2 cardiac rehabilitation following hospitalization. The study compares these two regimens to see which better improves aerobic capacity and physical function. During the study, participants aerobic fitness and physical function will be measured within four months after starting the exercise program. Tests include the 30-second sit-to-stand test and assessments of quality of life, depressive symptoms, executive function, physical function through a six-minute walk test, enjoyment of exercise, and anxiety. The study involves regular monitoring and safety assessments throughout to evaluate the effects of the training on participants recovery and functional abilities.
Actively Recruiting
Researchers are conducting a global, multicenter, and long-term observational study called the Pompe Disease Registry to track the natural history and outcomes of Pompe disease in patients, whether they are receiving treatment or not. This registry aims to improve understanding of the diseases variability, progression, and identification to better guide therapeutic interventions and patient care. The registry collects data from patients diagnosed with Pompe disease to characterize the disease population and evaluate the long-term effectiveness of alglucosidase alfa. It serves multiple purposes, including fulfilling regulatory commitments, supporting product development and reimbursement, and enabling other research and non-research uses. Participants provide information over many years, up to 30 years, helping researchers understand the diseases manifestations and progression. The registry gathers data that assists the medical community in developing monitoring recommendations and producing patient outcome reports to optimize care. Participation involves ongoing data collection but does not include experimental treatments or interventions.